Active Not Recruiting PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT06012500

Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease (Xe MRI in ILD)

Optimizing and Standardizing 129Xe Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease

Sponsor: Children's Hospital Medical Center, Cincinnati

Conditions ILD

Interventions Xenon-129

Updated 6 times since 2023 Last updated: Feb 11, 2026 Started: Apr 14, 2022 Primary completion: Dec 1, 2026 Completion: Dec 30, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06012500, this PHASE1/PHASE2 trial focuses on ILD and remains ongoing. Sponsored by Children's Hospital Medical Center, Cincinnati, it has been updated 6 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Feb 2026 — Present [monthly]

Active Not Recruiting PHASE1/PHASE2

Status: Recruiting → Active Not Recruiting · Phase: None → PHASE1/PHASE2
Oct 2025 — Feb 2026 [monthly]

Recruiting
Oct 2024 — Oct 2025 [monthly]

Recruiting
Sep 2024 — Oct 2024 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting

▶ Show 1 earlier version

Sep 2023 — Jul 2024 [monthly]

Recruiting

First recorded

Apr 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Children's Hospital Medical Center, Cincinnati

Data source: Children's Hospital Medical Center, Cincinnati

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cincinnati, United States